Eli Lillys Mounjaro KwikPen gains approval in India, targeting diabetes and obesity with its dual-action formula for weight ...

A WARNING has been issued to patients in Cumbria following the national rollout of the weight loss jab Mounjaro. Mounjaro is an antidiabetic drug which lowers blood sugar levels and slows down how ...

"Starmer needs a rethink and ensure savings are made from targeting people who can work, but who are currently out of the ...

India’s health regulator has approved Eli Lilly’s pre-filled pen version of Mounjaro, expanding its availability across six ...

Eli Lilly announced that its breakthrough drug, Mounjaro (tirzepatide), has received marketing authorization from India’s ...

With Novo Nordisk’s Wegovy already in the market, Eli Lilly is stepping up its game with a patient-friendly pen device, ...

If you or your family and friends take some weight loss medications, you'll want to read this. Some users are reporting ...

The UK's health regulator is investigating Ozempic and Mounjaro after linking the drugs to hundreds of severe illnesses and ...

Weight loss and diabetes jabs taken by more than a million people in the UK have been linked to a potential serious side effect, with some deaths, according to data from the UK medicines regulator.

The UK’s MHRA and Genomics England have launched a groundbreaking study to investigate whether genetics play a role in ...

Mounjaro is one of the bestselling weight loss drugs. See what your options are if you want to invest in Mounjaro stock.

Mounjaro, also known as tirzepatide, works by regulating the user’s appetite by mimicking a naturally produced hormone called glucagon-like peptide-1 (GLP-1). When we eat, GLP-1 is released and ...